Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 3.505 USD 3.7% Market Closed
Market Cap: 344.8m USD

Oncology Institute Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Oncology Institute Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Oncology Institute Inc
NASDAQ:TOI
Cash & Cash Equivalents
$49.7m
CAGR 3-Years
-24%
CAGR 5-Years
83%
CAGR 10-Years
N/A
Universal Health Services Inc
NYSE:UHS
Cash & Cash Equivalents
$112.9m
CAGR 3-Years
15%
CAGR 5-Years
-37%
CAGR 10-Years
11%
Encompass Health Corp
NYSE:EHC
Cash & Cash Equivalents
$48.7m
CAGR 3-Years
-7%
CAGR 5-Years
-36%
CAGR 10-Years
-24%
Tenet Healthcare Corp
NYSE:THC
Cash & Cash Equivalents
$3B
CAGR 3-Years
35%
CAGR 5-Years
-2%
CAGR 10-Years
21%
HCA Healthcare Inc
NYSE:HCA
Cash & Cash Equivalents
$997m
CAGR 3-Years
0%
CAGR 5-Years
-31%
CAGR 10-Years
5%
Ensign Group Inc
NASDAQ:ENSG
Cash & Cash Equivalents
$443.7m
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
27%
No Stocks Found

Oncology Institute Inc
Glance View

Market Cap
342m USD
Industry
Health Care

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

TOI Intrinsic Value
2.525 USD
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Oncology Institute Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
49.7m USD

Based on the financial report for Dec 31, 2024, Oncology Institute Inc's Cash & Cash Equivalents amounts to 49.7m USD.

What is Oncology Institute Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
83%

Over the last year, the Cash & Cash Equivalents growth was 48%. The average annual Cash & Cash Equivalents growth rates for Oncology Institute Inc have been -24% over the past three years , 83% over the past five years .

Back to Top